Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patients - Wikidata - awgldk - TriplyDB

Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patients

Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patients

http://www.wikidata.org/entity/Q35138666

about

Association of polymorphism harbored by tumor necrosis factor alpha gene and sex of calf with lactation performance in cattle Dipyrone & 2,5-dimethylcelecoxib suppress Th2-related chemokine production in monocyte.Etanercept biosimilars Inhibition of G-Protein βγ Signaling Decreases Levels of Messenger RNAs Encoding Proinflammatory Cytokines in T Cell Receptor-Stimulated CD4(+) T Helper Cells.Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists.T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy.The new use of an ancient remedy: a double-blinded randomized study on the treatment of rheumatoid arthritis.

P2860

Q28655822-C7C0C20D-BF65-4DCB-A81B-2BBD1980B563 Q34272055-9E72EE93-3F14-4D75-907A-EA7E1BFAD554 Q35020358-AF50D8AE-C071-4E86-B5F2-74CF9E3610EB Q36797406-D0A8C380-CCD7-4A93-9199-85348968CECA Q38239111-700FD9AA-731C-48D7-B4F0-F33C44D778A2 Q47131694-D5B2C3F1-49A1-416D-9262-43CCE8A0470E Q47770683-5E47A6EF-2F0E-46B5-BE04-FBF965777F27

P2860

Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patients

http://www.wikidata.org/entity/Q35138666

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Distinct effects of anti-tumor ...... rheumatoid arthritis patients

@ast

Distinct effects of anti-tumor ...... rheumatoid arthritis patients

@en

type

label

Distinct effects of anti-tumor ...... rheumatoid arthritis patients

@ast

Distinct effects of anti-tumor ...... rheumatoid arthritis patients

@en

prefLabel

Distinct effects of anti-tumor ...... rheumatoid arthritis patients

@ast

Distinct effects of anti-tumor ...... rheumatoid arthritis patients

@en

P1433

Q35138666-06D46BD3-61B0-45C6-9C58-606143B002D4

P1476

Q35138666-4A8ACDB4-E84A-4048-9637-ADBE7B385427

P2093

Q35138666-1FB30DDC-8D4C-4D3F-8062-8168A72BE8C6

Q35138666-662160CF-750D-4581-AB7D-E20A24E531D0

Q35138666-68304D2A-B06C-4391-B651-0EEDEA95FB79

Q35138666-B379D7EC-A69F-4DD8-8344-E875A21BF7FF

Q35138666-DAF302B2-ADB1-4272-AA49-8CD76AC59F18

Q35138666-FD0CB1FB-7661-48E7-AD8A-5120A5857300

P2860

Q35138666-05A51D5C-B69E-4A7F-AD32-E8177877A8B6

Q35138666-12D93F63-0458-4C59-984A-16C2C243E2FC

Q35138666-303AF865-174C-4BF5-A063-24F4B5B271D2

Q35138666-352C0A7B-8291-486B-99B9-9A876350072F

Q35138666-3EDF5A0A-254B-485D-B99C-94766A83916C

Q35138666-3F7A6F18-B02F-4562-A56A-B39F2ED82FBB

Q35138666-4586FA2A-78DD-4AA3-8F3D-0C7880888CB4

Q35138666-4C55FDAD-9C9B-414D-A60D-23A8B11FCAC2

Q35138666-5690D21B-0C8A-4495-834D-BDF466EB651D

Q35138666-5A3E34C8-5262-4452-AD9E-8900BCF06E21

P304

Q35138666-06BB0902-8E89-417D-B017-2763C11515B1

P31

Q35138666-84ACD16B-3E88-41F0-9FBD-A928B21E2F1C

Q35138666-c4a42f34-1649-4e11-869f-715cdbecea52

P356

Q35138666-79D90998-BAB1-45C3-B400-3DFF706C8F58

P433

Q35138666-3A29AD7A-D70A-4242-8AF6-3A140343FD1A

P478

Q35138666-DD6A3452-78B1-4D0A-A3CF-9723F3713908

P50

Q35138666-46C28A34-53BF-4F01-B0E0-B8139BF1D996

P577

Q35138666-A231FBD4-7FD9-4280-A249-3888D6D62553

P698

Q35138666-BD3CB5D9-85EA-429B-AE69-428C1E51E11F

P932

Q35138666-22356080-1A47-461C-B58B-BA8A786329D3

P356

P1433

Clinical and Vaccine Immunology

P1476

Distinct effects of anti-tumor ...... rheumatoid arthritis patients

@en

P2093

A Shinberg

http://www.w3.org/2001/XMLSchema#string

M Deutsch

http://www.w3.org/2001/XMLSchema#string

M Ehrenfeld

http://www.w3.org/2001/XMLSchema#string

N Zurgil

http://www.w3.org/2001/XMLSchema#string

S Herman

http://www.w3.org/2001/XMLSchema#string

S Machlav

http://www.w3.org/2001/XMLSchema#string

P2860

Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?

Anti-cytokine therapy for rheumatoid arthritis.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

The role of T cells in rheumatoid arthritis.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis.

The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.

P304

1077-1082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00061-11

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Pnina Langevitz

P577

2011-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21593236

http://www.w3.org/2001/XMLSchema#string

P932

3147326

http://www.w3.org/2001/XMLSchema#string